Abstract
In an effort to develop a quantitative ligand-binding model for the CB1R, pharmacophore modelling studies were performed on 1-sulfonyl 4-acylpiperazine derivatives. Pharmacophore Alignment and Scoring Engine (PHASE) was used to develop predictive Common Pharmacophore Hypotheses (CPHs) in which a five point pharmacophore with one hydrogen bond acceptor (A), two lipophilic/hydrophobic groups (H) and two aromatic rings (R) as pharmacophoric features was developed. On the basis of statistical values, the best-fitted model was identified and the same alignment was used for CoMFA and CoMSIA studies. The models developed showed an excellent r2 predictive value of 0.879 for CoMFA and 0.764 for CoMSIA. The robustness of the models was validated and the mean activity for test set compounds can estimate external predictivity. The 3D contour maps generated from CoMFA/CoMSIA offer important structural insights and provided interpretable explanation of SAR for the compounds. The obtained results may help in designing analogs with better activity.
Keywords: CB1R, CoMFA, CoMSIA, 3D-QSAR, Endocannabinoid, Obesity, PHASE, ligand-binding model, pharmacophoric features, 3D contour maps, endocannabinoid system, anti-obesity therapeutics, metabolic homeostasis, cannabinoid CB1 inverse agonists, 1-sulfonyl-4-acylpiperazines, 3D-pharmacophore model, GPCR ligand binding modes
Letters in Drug Design & Discovery
Title: Pharmacophore and 3D-QSAR Studies on 1-Sulfonyl-4-acylpiperazines as Selective Cannabinoid-1 Receptor (CB1R) Inverse Agonists
Volume: 8 Issue: 7
Author(s): Vikas N. Telvekar, Lalit B. Thakur, Prashant B. Jagdhane and Yogesh D. Manohar
Affiliation:
Keywords: CB1R, CoMFA, CoMSIA, 3D-QSAR, Endocannabinoid, Obesity, PHASE, ligand-binding model, pharmacophoric features, 3D contour maps, endocannabinoid system, anti-obesity therapeutics, metabolic homeostasis, cannabinoid CB1 inverse agonists, 1-sulfonyl-4-acylpiperazines, 3D-pharmacophore model, GPCR ligand binding modes
Abstract: In an effort to develop a quantitative ligand-binding model for the CB1R, pharmacophore modelling studies were performed on 1-sulfonyl 4-acylpiperazine derivatives. Pharmacophore Alignment and Scoring Engine (PHASE) was used to develop predictive Common Pharmacophore Hypotheses (CPHs) in which a five point pharmacophore with one hydrogen bond acceptor (A), two lipophilic/hydrophobic groups (H) and two aromatic rings (R) as pharmacophoric features was developed. On the basis of statistical values, the best-fitted model was identified and the same alignment was used for CoMFA and CoMSIA studies. The models developed showed an excellent r2 predictive value of 0.879 for CoMFA and 0.764 for CoMSIA. The robustness of the models was validated and the mean activity for test set compounds can estimate external predictivity. The 3D contour maps generated from CoMFA/CoMSIA offer important structural insights and provided interpretable explanation of SAR for the compounds. The obtained results may help in designing analogs with better activity.
Export Options
About this article
Cite this article as:
N. Telvekar Vikas, B. Thakur Lalit, B. Jagdhane Prashant and D. Manohar Yogesh, Pharmacophore and 3D-QSAR Studies on 1-Sulfonyl-4-acylpiperazines as Selective Cannabinoid-1 Receptor (CB1R) Inverse Agonists, Letters in Drug Design & Discovery 2011; 8 (7) . https://dx.doi.org/10.2174/157018011796235284
DOI https://dx.doi.org/10.2174/157018011796235284 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Preface [Hot topic: Anti-Hypertensive Agents in Relation to Modifying Coronary Risk Factors (Executive Editor : Aurelio Leone)]
Current Pharmaceutical Design Vascular, Oxidative, and Synaptosomal Abnormalities During Aging and the Progression of Type 2 Diabetes
Current Neurovascular Research Antiplatelet Therapy in Patients with Diabetes Mellitus
Current Vascular Pharmacology Membrane-Targeted Self-Assembling Cyclic Peptide Nanotubes
Current Topics in Medicinal Chemistry <i>In-silico</i> Screening of Phytoconstituents on Wound Healing Targets - Approaches and Current Status
Current Drug Discovery Technologies Targeting Iron Acquisition by Mycobacterium tuberculosis
Infectious Disorders - Drug Targets Silencing Human Cancer: Identification and Uses of MicroRNAs
Recent Patents on Anti-Cancer Drug Discovery Rab GTPases, Membrane Trafficking and Diseases
Current Drug Targets Colesevelam: A New and Improved Bile Acid Sequestrant?
Current Pharmaceutical Design Personalized Medicine, Bioethics and Social Responsibilities: Re-thinking the Pharmaceutical Industry to Remedy Inequities in Patient Care and International Health
Current Pharmacogenomics and Personalized Medicine Nitrite as a Physiological Source of Nitric Oxide and a Signalling Molecule in the Regulation of the Cardiovascular System in Both Mammalian and Non-Mammalian Vertebrates
Recent Patents on Cardiovascular Drug Discovery Potential Application of Plant-derived Bioengineered Human VEGF for Tissue Regeneration
Current Pharmaceutical Biotechnology Oxindole Derivatives: Synthesis and Antiglycation Activity
Medicinal Chemistry The Evolving Roles of Nuclear Cardiology
Current Cardiology Reviews Uric acid and Metabolic Syndrome: What is the Relationship?
Current Rheumatology Reviews Regulatory Role of Heat Shock Proteins in the Pathogenesis of Type 1 and Type 2 Diabetes
Current Immunology Reviews (Discontinued) Signaling Pathways Underpinning the Manifestations of Ionizing Radiation-Induced Bystander Effects
Current Molecular Pharmacology Immune Mechanism, Aging, Season and Diseases: Modulatory Role of Melatonin
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) The Complex Relationship Between Diabetes and Cardiac Arrhythmias: Pathophysiology and Mechanisms
Current Pharmaceutical Design Anti-obesity Agents: A Focused Review on the Structural Classification of Therapeutic Entities
Current Topics in Medicinal Chemistry